JY
FURX

Jeff Yass’s FURIEX PHARMACEUTICALS INC COM STK (DE) FURX Stock Holding History

Jeff Yass’s Portfolio FURX Stock Details FURX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-40,300
Closed -$4.28M – 10571
2014
Q2 		$4.28M Sell
40,300
-129,500
-76% -$12.7M ﹤0.01% 3336
2014
Q1 		$14.8M Buy
169,800
+132,700
+358% +$10.2M 0.01% 1569
2013
Q4 		$1.56M Buy
37,100
+1,900
+5% +$78.1K ﹤0.01% 4705
2013
Q3 		$1.55M Buy
+35,200
New +$1.46M ﹤0.01% 4544

Jeff Yass's FURX Position: Q3 2014 in Review

Jeff Yass sold out of FURIEX PHARMACEUTICALS INC COM STK (DE) (FURX) in Q3 2014, closing a stake of 213,121 shares — an estimated $22.6M sold.

Jeff Yass first reported a position in FURX in Q2 2013 and held it in 4 quarters. The position peaked at $22.6M in Q2 2014. 0 funds tracked by Wall St. Rank hold FURX as of Q3 2014.

  • Jeff Yass reported no remaining FURIEX PHARMACEUTICALS INC COM STK (DE) position as of Q3 2014 after selling out during the quarter.
  • Jeff Yass sold 213,121 FURIEX PHARMACEUTICALS INC COM STK (DE) shares in Q3 2014, an estimated $22.6M.
  • Jeff Yass first reported a position in FURIEX PHARMACEUTICALS INC COM STK (DE) in Q2 2013 and held it in 4 quarters.
  • Jeff Yass's FURIEX PHARMACEUTICALS INC COM STK (DE) position peaked at $22.6M in Q2 2014.
  • 0 funds tracked by Wall St. Rank held FURIEX PHARMACEUTICALS INC COM STK (DE) as of Q3 2014.

Based on Susquehanna International Group's 13F filing for Q3 2014, filed 17 Nov 2014.